1. Home
  2. ELMD vs NKTX Comparison

ELMD vs NKTX Comparison

Compare ELMD & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electromed Inc.

ELMD

Electromed Inc.

HOLD

Current Price

$25.58

Market Cap

208.1M

Sector

Health Care

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.95

Market Cap

247.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELMD
NKTX
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.1M
247.4M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
ELMD
NKTX
Price
$25.58
$2.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$36.00
$11.33
AVG Volume (30 Days)
25.2K
960.2K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
46.55
11.88
EPS
0.56
N/A
Revenue
$54,716,000.00
N/A
Revenue This Year
$15.59
N/A
Revenue Next Year
$11.51
N/A
P/E Ratio
$45.97
N/A
Revenue Growth
13.83
N/A
52 Week Low
$17.73
$1.63
52 Week High
$30.73
$3.65

Technical Indicators

Market Signals
Indicator
ELMD
NKTX
Relative Strength Index (RSI) 53.57 58.40
Support Level $23.29 $1.88
Resistance Level $26.84 $3.65
Average True Range (ATR) 0.77 0.28
MACD 0.01 -0.02
Stochastic Oscillator 41.40 49.64

Price Performance

Historical Comparison
ELMD
NKTX

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: